Interestingly, the risk alleles for dyslipidemia of NAT2 gene (e.g., rs1495741-A) are associated with the rapid acetylator phenotype in humans (Hong et al., 2023), which suggests that individuals with increased levels of NAT2 activity are at a higher risk of developing dyslipidemia. The gene discussed is NAT2; the disease is metabolic syndrome.